Clene Nanomedicine
Biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases. Learn more
Launch date
Employees
Market cap
CAD55.9m
Enterprise valuation
CAD71m (Public information from Sep 2024)
Share price
$5.19 CLNN
Salt Lake City Utah (HQ)
Authorizing premium user...